MYX mayne pharma group limited

Would dearly like to see CEO gone should have happened after the...

  1. 1,467 Posts.
    lightbulb Created with Sketch. 289
    Would dearly like to see CEO gone should have happened after the extent of the Teva monumental damage done to the company was known the entire company put in a precarious position . Can take years to restore lost market sentiment / trust if ever , we're still in that position think we're far from recovered SR relying on Nextstellis " game changer " all retail investors holding Mayne deserve something really big to happen such as successfully tapping into a market like the US . ( Aust . market too small) only reason not wanting CEO dumped now is timing why risk bring the roof down on top of ourselves knowing he has support from our biggest shareholders plus share value weak as it is .29-30 the last thing we need is some major holder/s dumping including SR major holding , our lenders would be looking at the risk to them also financially heavily invested in what now seems generally considered a high risk investment $520 Cap company reporting large net loses last 5 years can hardly risk getting off side with them doing anything that might affect our abysmal Market Cap . Hopefully E4 shows promise and market sentiment improves , safer time for a major Managerial overhaul to get us where we should managed competently , short term could be risk rocking the boat .
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.92
Change
-0.110(2.19%)
Mkt cap ! $399.7M
Open High Low Value Volume
$5.03 $5.03 $4.86 $1.730M 352.1K

Buyers (Bids)

No. Vol. Price($)
1 100 $4.88
 

Sellers (Offers)

Price($) Vol. No.
$4.93 25000 1
View Market Depth
Last trade - 16.15pm 23/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.